CasLoc logo
All Cases PTAB Litigations UPC Oppositions

ARS PHARMACEUTICALS OPERATIONS, INC. v. LUPIN INC.

2:25-cv-15123

Overview

Case Number 2:25-cv-15123
Filing Date 2025-08-29
Status Litigation filed
Court District Court, D. New Jersey (njd)
Nature of Suit 835 Patent - Abbreviated New Drug Application(ANDA)
Jurisdiction Type Federal Question
Cause of Action 28:1338 Patent Infringement
Jury Demand None

Parties

Defendant

LUPIN PHARMACEUTICALS, INC. Operating Company

Represented By

5 Attorneys Listed

MICHAEL W. JOHNSON

GEMINI LAW LLP

Tel: +1 (917) 915-8832

COUNSEL NOT ADMITTED TO USDC - NJ BAR, 32 W 39TH STREET

JASON N. ZACCARO

GEMINI LAW LLP

Tel: +1 (917) 915-8832

COUNSEL NOT ADMITTED TO USDC - NJ BAR, 32 W 39TH STREET

HEATHER M. SCHNEIDER

GEMINI LAW LLP

Tel: +1 (917) 915-8832

COUNSEL NOT ADMITTED TO USDC - NJ BAR, 32 W 39TH STREET

ERIC L. SAUNDERS

GEMINI LAW LLP

Tel: +1 (917) 915-8832

COUNSEL NOT ADMITTED TO USDC - NJ BAR, 32 W 39TH STREET

JAMES S. RICHTER

MIDLIGE RICHTER LLC

Tel: +1 (908) 626-0622

MIDLIGE RICHTER LLC, 121 UNION AVENUE

LUPIN LTD. Operating Company

Represented By

1 Attorneys Listed

JAMES S. RICHTER

MIDLIGE RICHTER LLC

Tel: +1 (908) 626-0622

MIDLIGE RICHTER LLC, 121 UNION AVENUE

LUPIN INC. Operating Company

Represented By

5 Attorneys Listed

MICHAEL W. JOHNSON

GEMINI LAW LLP

Tel: +1 (917) 915-8832

COUNSEL NOT ADMITTED TO USDC - NJ BAR, 32 W 39TH STREET

JASON N. ZACCARO

GEMINI LAW LLP

Tel: +1 (917) 915-8832

COUNSEL NOT ADMITTED TO USDC - NJ BAR, 32 W 39TH STREET

HEATHER M. SCHNEIDER

GEMINI LAW LLP

Tel: +1 (917) 915-8832

COUNSEL NOT ADMITTED TO USDC - NJ BAR, 32 W 39TH STREET

ERIC L. SAUNDERS

GEMINI LAW LLP

Tel: +1 (917) 915-8832

COUNSEL NOT ADMITTED TO USDC - NJ BAR, 32 W 39TH STREET

JAMES S. RICHTER

MIDLIGE RICHTER LLC

Tel: +1 (908) 626-0622

MIDLIGE RICHTER LLC, 121 UNION AVENUE

Plaintiff

AEGIS THERAPEUTICS, LLC Operating Company

Represented By

4 Attorneys Listed

TRACY ELLEN BLOCK

COUNSEL NOT ADMITTED TO USDC - NJ BAR

Tel: +1 (212) 335-4733

COUNSEL NOT ADMITTED TO USDC - NJ BAR, DLA PIPER

PAUL STEADMAN

COUNSEL NOT ADMITTED TO USDC - NJ BAR

Tel: +1 (312) 368-2135

COUNSEL NOT ADMITTED TO USDC - NJ BAR, DLA PIPER

CYNTHIA STENCEL BETZ

MCCARTER & ENGLISH, LLP

Tel: +1 (973) 622-4444
Fax: +1 (973) 624-7070

FOUR GATEWAY CENTER, 100 MULBERRY STREET

MARK M. MAKHAIL

MCCARTER & ENGLISH, LLP

Tel: +1 (973) 639-2092

4 GATEWAY CENTER, 100 MULBERRY ST.

ARS PHARMACEUTICALS OPERATIONS, INC. Operating Company

Represented By

9 Attorneys Listed

CYNTHIA STENCEL BETZ

MCCARTER & ENGLISH, LLP

Tel: +1 (973) 622-4444
Fax: +1 (973) 624-7070

FOUR GATEWAY CENTER, 100 MULBERRY STREET

THOMAS H. WINTNER

Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo, P.C.

Tel: +1 (617) 348-1625

COUNSEL NOT ADMITTED TO USDC - NJ BAR, One Financial Center

SAMANTHA L. COHEN

MINTZ, LEVIN, COHN, FERRIS, GLOVSKY AND POPEO, P.C.

Tel: +1 (617) 348-4851

COUNSEL NOT ADMITTED TO USDC - NJ BAR, ONE FINANCIAL CENTER

PETER J. CUOMO

Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo, P.C.

Tel: +1 (617) 348-1854

COUNSEL NOT ADMITTED TO USDC - NJ BAR, One Financial Center

NANA LIU

Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo, P.C.

Tel: +1 (415) 432-6004

COUNSEL NOT ADMITTED TO USDC - NJ BAR, 44 Montgomery Street

JOSEPH D. RUTKOWSKI

MINTZ, LEVIN, COHEN, FERRIS, GLOVSKY AND POPEO, P.C.

Tel: +1 (617) 348-1873

COUNSEL NOT ADMITTED TO USDC - NJ BAR, ONE FINANCIAL CENTER

AMANDA METELL

MINTZ, LEVIN, COHN, FERRIS, GLOVSKY AND POPEO, P.C.

Tel: +1 (617) 239-8254

COUNSEL NOT ADMITTED TO USDC-NJ BAR, ONE FINANCIAL CENTER

ADAM P. SAMANSKY

Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo, P.C.

Tel: +1 (617) 348-1819

COUNSEL NOT ADMITTED TO USDC - NJ BAR, One Financial Center

MARK M. MAKHAIL

MCCARTER & ENGLISH, LLP

Tel: +1 (973) 639-2092

4 GATEWAY CENTER, 100 MULBERRY ST.

Consolidated Defendant

CIPLA USA, INC. Operating Company

Represented By

1 Attorneys Listed

REBEKAH R. CONROY

STONE CONROY LLC

Tel: +1 (973) 400-4181
Fax: +1 (973) 498-0070

STONE CONROY LLC, 25A HANOVER ROAD

CIPLA LTD. Operating Company

Represented By

1 Attorneys Listed

REBEKAH R. CONROY

STONE CONROY LLC

Tel: +1 (973) 400-4181
Fax: +1 (973) 498-0070

STONE CONROY LLC, 25A HANOVER ROAD

Court & Judges

Court

District Court, D. New Jersey (njd)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 25 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (25): 🇨🇦 Canada CN 🇩🇪 Germany 🇪🇺 Europe GB 🇯🇵 Japan KR 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

8 Patents

There are 8 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US10576156
Compositions for drug administration
Filed: 2018-02-06
Issued: 2020-03-03
Active (11.2 yrs remaining)
Expires: 2038-02-06
US10682414
Intranasal epinephrine formulations and methods for the treatment of disease
Filed: 2019-05-22
Issued: 2020-06-16
Active (12.5 yrs remaining)
Expires: 2039-05-22
US11173209
Compositions for drug administration
Filed: 2019-11-08
Issued: 2021-11-16
Active (13.0 yrs remaining)
Expires: 2039-11-08
US11191838
Intranasal epinephrine formulations and methods for the treatment of disease
Filed: 2020-05-07
Issued: 2021-12-07
Active (13.5 yrs remaining)
Expires: 2040-05-07
US11717571
Intranasal epinephrine formulations and methods for the treatment of disease
Filed: 2022-10-26
Issued: 2023-08-08
Active (12.2 yrs remaining)
Expires: 2039-02-06

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

33

Dispositive

9

Granted

18

Denied

1

Pending / Review

9

Motions by Category

Procedural / Extension Motion 21 Motion to Dismiss 9 Claim Construction / Markman Filing 3

Key Dispositive Motions & Rulings

Motion to Dismiss Denied
TEXT ORDER - On September 3, 2026, Plaintiffs ARS Pharmaceuticals Operations, Inc. and Aegis Therapeutics, LLC (collectively, "Plaintiffs") and Defendants Lupin...
Entry #85 • 2026-09-04 Document →
Motion to Dismiss Pending
Order on Motion to Dismiss
Entry #— • 2026-09-04
Motion to Dismiss Pending / Under Review
REPLY BRIEF to Opposition to Motion filed by AEGIS THERAPEUTICS, LLC, ARS PHARMACEUTICALS OPERATIONS, INC. re 40 MOTION to Dismiss Counterclaims and to Strike A...
Entry #55 • 2026-03-03 Document →
Motion to Dismiss Pending / Under Review
Letter from Plaintiffs Requesting Extension of Deadline to File Reply to Defendants' Opposition to Motion to Dismiss re Set/Reset Motion and R&R Deadlines/Heari...
Entry #48 • 2026-02-20 Document →
Motion to Dismiss Pending / Under Review
BRIEF in Opposition filed by LUPIN INC., LUPIN PHARMACEUTICALS, INC. re 40 MOTION to Dismiss Counterclaims and to Strike Affirmative Defense (RICHTER, JAMES) (E...
Entry #47 • 2026-02-17 Document →
Motion to Dismiss Pending
Set Deadlines as to 40 MOTION to Dismiss Counterclaims and to Strike Affirmative Defense. Motion set for 3/2/2026 before Judge Julien Xavier Neals. Unless other...
Entry #— • 2026-01-29

Docket Entries

(218 total)
Pleading / Complaint

COMPLAINT against LUPIN INC., LUPIN LTD., LUPIN PHARMACEUTICALS, INC. ( Filing and Admin fee $ 405 receipt number ANJDC-16608013), filed by ARS PHARMACEUTICALS OPERATIONS, INC., AEGIS THERAPEUTICS, LLC. (Attachments: # 1 Exhibit A - U.S. Patent No. 10,576,156, # 2 Exhibit B - U.S. Patent No. 10,682,414, # 3 Exhibit U.S. Patent No. 11,173,209, # 4 Exhibit D - U.S. Patent No. 11,191,838, # 5 Exhibit E - U.S. Patent No 11,717,571, # 6 Exhibit F - U.S. Patent No. 11,744,895, # 7 Exhibit G - U.S. Patent No. 11,918,655, # 8 Exhibit H - U.S. Patent No. 12,324,838, # 9 Civil Cover Sheet)(BETZ, CYNTHIA) (Entered: 08/29/2025)

Entry #1 • 2025-08-29
1
Pleading / Complaint

COMPLAINT against LUPIN INC., LUPIN LTD., LUPIN PHARMACEUTICALS, INC. ( Filing and Admin fee $ 405 receipt number ANJDC-16608013), filed by ARS PHARMACEUTICALS OPERATIONS, INC., AEGIS THERAPEUTICS, LLC. (Attachments: # 1 Exhibit A - U.S. Patent No. 10,576,156, # 2 Exhibit B - U.S. Patent No. 10,682,414, # 3 Exhibit U.S. Patent No. 11,173,209, # 4 Exhibit D - U.S. Patent No. 11,191,838, # 5 Exhibit E - U.S. Patent No 11,717,571, # 6 Exhibit F - U.S. Patent No. 11,744,895, # 7 Exhibit G - U.S. Patent No. 11,918,655, # 8 Exhibit H - U.S. Patent No. 12,324,838, # 9 Civil Cover Sheet)(BETZ, CYNTHIA) (Entered: 08/29/2025)

Entry #1 • 2025-08-29
2
Pleading / Complaint

COMPLAINT against LUPIN INC., LUPIN LTD., LUPIN PHARMACEUTICALS, INC. ( Filing and Admin fee $ 405 receipt number ANJDC-16608013), filed by ARS PHARMACEUTICALS OPERATIONS, INC., AEGIS THERAPEUTICS, LLC. (Attachments: # 1 Exhibit A - U.S. Patent No. 10,576,156, # 2 Exhibit B - U.S. Patent No. 10,682,414, # 3 Exhibit U.S. Patent No. 11,173,209, # 4 Exhibit D - U.S. Patent No. 11,191,838, # 5 Exhibit E - U.S. Patent No 11,717,571, # 6 Exhibit F - U.S. Patent No. 11,744,895, # 7 Exhibit G - U.S. Patent No. 11,918,655, # 8 Exhibit H - U.S. Patent No. 12,324,838, # 9 Civil Cover Sheet)(BETZ, CYNTHIA) (Entered: 08/29/2025)

Entry #1 • 2025-08-29
2
Pleading / Complaint

COMPLAINT against LUPIN INC., LUPIN LTD., LUPIN PHARMACEUTICALS, INC. ( Filing and Admin fee $ 405 receipt number ANJDC-16608013), filed by ARS PHARMACEUTICALS OPERATIONS, INC., AEGIS THERAPEUTICS, LLC. (Attachments: # 1 Exhibit A - U.S. Patent No. 10,576,156, # 2 Exhibit B - U.S. Patent No. 10,682,414, # 3 Exhibit U.S. Patent No. 11,173,209, # 4 Exhibit D - U.S. Patent No. 11,191,838, # 5 Exhibit E - U.S. Patent No 11,717,571, # 6 Exhibit F - U.S. Patent No. 11,744,895, # 7 Exhibit G - U.S. Patent No. 11,918,655, # 8 Exhibit H - U.S. Patent No. 12,324,838, # 9 Civil Cover Sheet)(BETZ, CYNTHIA) (Entered: 08/29/2025)

Entry #1 • 2025-08-29
2
Pleading / Complaint

COMPLAINT against LUPIN INC., LUPIN LTD., LUPIN PHARMACEUTICALS, INC. ( Filing and Admin fee $ 405 receipt number ANJDC-16608013), filed by ARS PHARMACEUTICALS OPERATIONS, INC., AEGIS THERAPEUTICS, LLC. (Attachments: # 1 Exhibit A - U.S. Patent No. 10,576,156, # 2 Exhibit B - U.S. Patent No. 10,682,414, # 3 Exhibit U.S. Patent No. 11,173,209, # 4 Exhibit D - U.S. Patent No. 11,191,838, # 5 Exhibit E - U.S. Patent No 11,717,571, # 6 Exhibit F - U.S. Patent No. 11,744,895, # 7 Exhibit G - U.S. Patent No. 11,918,655, # 8 Exhibit H - U.S. Patent No. 12,324,838, # 9 Civil Cover Sheet)(BETZ, CYNTHIA) (Entered: 08/29/2025)

Entry #1 • 2025-08-29
2

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc